Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-29

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for a generic zolpidem tartrate product (ANDA 204299). Zolpidem tartrate is used for the short-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)